公司资料
Bone Biologics 股价、新闻与催化剂
- 股票代码:
- BBLG
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.63 USD (+3.50%)
收盘价
最后更新: 2026年8月21日
2.28M USD
市值
股价为何变动
As of Aug 21, 2026, BBLG closed up 3.50% at $0.6262. No new same-company headline was identified in the current news window.
公司概览
业务概览
Bone Biologics is a biotechnology company focused on bone regeneration and spinal fusion support products. Its story centers on using biologic materials to improve orthopedic healing.
所在地与行业分类
Bone Biologics is headquartered in the United States and listed on NASDAQ. It sits in regenerative medicine and orthopedic biotechnology.
商业模式特征
The company depends on clinical and preclinical progress, product development, and the ability to create a differentiated bone-growth platform. Investors usually watch data, regulatory steps, and capital runway.
生物医药行业定位
Bone Biologics occupies a small orthopedic-regeneration niche within biotech. The stock is sensitive to whether its biologic platform can translate into meaningful surgical use.
未来催化剂
- Bone Biologics’ catalysts are NELL-1 / spine-regeneration work and any update that shows the platform can still progress clinically. The company remains highly dependent on proof of concept.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。